| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 07/15/2004 | US20040138203 Antiserotonine agents |
| 07/15/2004 | US20040138186 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 07/15/2004 | US20040138148 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 07/15/2004 | US20040138146 Methods for preventing or treating cardiac arrhythmia |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138110 administering plasminogen activator inhibitors comprising cyclic peptides as antitumor agents; tissue-targeted therapy |
| 07/15/2004 | US20040137612 Bone marrow multipotent stem cells for propagation of osteoblast, chrondrocytes, myoblasts, adipocytes, endothelial and neuronal tissues; tissue engineering |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137556 Yeast strains autonomously producing steroids |
| 07/15/2004 | US20040137521 Method for apo clll measurement in apo b and non apo b containing particles |
| 07/15/2004 | US20040137513 Agonist anti-trk-c monoclonal antibodies |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136983 as anti-tumor agent or treating excessive vascular permeability; agonist for treating trauma to vascular network |
| 07/15/2004 | US20040136979 block, retard or reduce connective tissues regeneration; molecules released by catheters, surgical instruments or stents for angioplasty to prevent restenosis; atherosclerosis |
| 07/15/2004 | US20040136957 administering a therapeutically relevant dose of IFN (interferon) type-I or a functional part, derivative and/or analogue thereof |
| 07/15/2004 | CA2511500A1 Novel ethylenediamine derivatives |
| 07/15/2004 | CA2509835A1 Nitrogen-containing heterocyclic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437339A1 Substituted benzoic acid derivatives exhibiting nf-kappa b inhibiting activity |
| 07/14/2004 | EP1437140A1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 07/14/2004 | EP1437137A1 Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 07/14/2004 | EP1437132A1 Use of nitric ester derivatives in the manufacture of a medicament for the treatment of gastrointestinal tumors |
| 07/14/2004 | EP1437131A1 Use of an ACE inhibitor for the prevention of diabetes in a patient with no preexisting congestive heart failure |
| 07/14/2004 | EP1437043A1 Model animal with overexpression of regucalcin |
| 07/14/2004 | EP1436623A1 Modulation of tor |
| 07/14/2004 | EP1436395A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 07/14/2004 | EP1436392A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436382A2 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 07/14/2004 | EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436326A2 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436323A1 Crystal structure of baff, and use thereof in drug design |
| 07/14/2004 | EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/14/2004 | EP1436313A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/14/2004 | EP1436298A1 Himbacine analogues as thrombin receptor antagonists |
| 07/14/2004 | EP1436292A1 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists |
| 07/14/2004 | EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor |
| 07/14/2004 | EP1436283A1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 07/14/2004 | EP1436279A1 Chemical compounds |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 07/14/2004 | EP1436252A1 Hydroxyfattysulfonic acid analogs |
| 07/14/2004 | EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 07/14/2004 | EP1436009A1 Pharmaceutical formulation |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1435986A2 Igf-binding protein-derived peptide or small molecule |
| 07/14/2004 | EP1435983A1 Concentrate comprising green tea, grape skin extract and grape seed extract, the production thereof and the use of the same |
| 07/14/2004 | EP1435973A1 Coadministration of transport protein with conjugated cobalamin to deliver agents |
| 07/14/2004 | EP1435972A2 Novel synthetic ganglioside derivatives and compositions thereof |
| 07/14/2004 | EP1435968A1 Combinations comprising cox-2 inhibitors and aspirin |
| 07/14/2004 | EP1435960A1 Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 07/14/2004 | EP1435958A1 Use of phosphorodiesterase iv inhibitors |
| 07/14/2004 | EP1435957A2 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/14/2004 | EP1435954A1 High purity amlodipine benzenesulfonate and a process for its preparation |
| 07/14/2004 | EP1435952A1 8-amino- 1,2,4]triazolo 1,5-a]pyridine-6-carboxylic acid amide |
| 07/14/2004 | EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 07/14/2004 | EP1435946A2 Linked biaryl compounds |
| 07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435930A2 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435906A2 Method for producing biologically active products |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1372689B1 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1315793A4 Methods for culturing human lung mast cells and uses thereof |
| 07/14/2004 | EP1254120B1 Use of pyrimidine endothelin antagonists in companion animals |
| 07/14/2004 | EP1248776B1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1009427A4 USE OF FACTOR XIIIa INHIBITORS TO TREAT ATHEROSCLEROSIS |
| 07/14/2004 | CN1512988A Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1512887A Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 07/14/2004 | CN1512885A Pharmaceutical combinations |
| 07/14/2004 | CN1511952A Recombined glucokinase |
| 07/14/2004 | CN1511840A Puerarin compound containing water soluble group and its preparation and use |
| 07/14/2004 | CN1511838A Triptolide alcohol derivative and its use |